AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
loading page
this is for holding javascript data
DOWNLOAD
Download ZIP
Download LaTeX
Track citations
Fork (make a copy)
218
1
Backstory of: A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density
Backstories
,
Robert Recker
Backstories
Backstories
Corresponding Author:
[email protected]
Author Profile
Robert Recker
Creighton University
Author Profile
×
OK